All AbMole products are for research use only, cannot be used for human consumption.
GIBH-130 is a neuroinflammation inhibitor, with IC50 value of 3.4 nM for suppressing the IL-1β secretion by activated microglia. GIBH-130 exhibited comparable in vivo efficacy of cognitive impairment relief to donepezil and memantine respectively in both β amyloid-induced and APP/PS1 double transgenic Alzheimer's murine models at a substantially lower dose (0.25 mg/kg). GIBH-130 is found to be orally bioavailable in rats, with 74.91% bioavailability and 4.32 h half-life.
Molecular Weight | 360.41 |
Formula | C20H20N6O |
CAS Number | 1252608-59-5 |
Solubility (25°C) | DMSO 44 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Related IL Receptor/Related Products |
---|
Perfluorodecanoic acid
Perfluorodecanoic acid (PFDA) is widely used as surfactants, polymer and plastic additives, wetting agents, corrosion inhibitors, lubricants, foam-fire extinguishants, etc. Perfluorodecanoic acid induces weight loss and increases liver weight and lipid content in mice. Perfluorodecanoic acid also reduces mRNA expression of the genes encoding IL-1β, IL-18, and cellular inhibitor of apoptosis 2 (cIAP2), as well as caspase-1, -3, and -7 in mouse liver. |
IL-15-IN-1
IL-15-IN-1 is a potent and selective Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells with an IC50 of 0.8 μM. |
IL-17 modulator 3
IL-17 modulator 3 is an IL-17 modulator. |
IL-17 modulator 4
IL-17 modulator 4 is a proagent of IL-17 modulator 1. |
IL-17A modulator-3
IL-17A modulator-3 is a IL-17A modulator. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.